Simple spray cuts pain after hernia surgery, study finds
NCT ID NCT07208253
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested whether spraying a mix of two common medicines, dexamethasone and bupivacaine, onto the surgical mesh during laparoscopic hernia repair could reduce pain afterward. 175 adults having elective hernia surgery were randomly assigned to receive the spray or no local treatment. Those who got the spray reported less pain, needed fewer extra painkillers, and were more satisfied with their recovery.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- dexamethasone and bupivacaine
- What this could lead to
- If confirmed, this simple spray could become a standard way to ease pain and improve comfort after laparoscopic hernia surgery.
- What could go wrong
- This is a single completed study with 175 patients. The results may not apply to all hernia surgeries or patients, and the long-term effects are not yet known.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
175 people
The number who actually took part.
- Started
-
Apr 2021
- Finished
-
Jan 2023
- Lead sponsor
-
A government agency
The lead sponsor is a government body.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Adults (≥18 years old) scheduled for elective unilateral inguinal hernia repair with the laparoscopic total extraperitoneal (TEP) technique * American Society of Anesthesiologists (ASA) physical status I-II * Ability to provide informed consent Exclusion Criteria: * Age \<18 years * ASA physical status ≥III * Recurrent or bilateral inguinal hernia * History of allergy to local anesthetics or corticosteroids * Chronic opioid use or dependence * Severe hepatic, renal, or cardiac disease * Pregnancy or breastfeeding * Patients who declined to participate or could not provide consent
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Inguinal hernia repair (not urgent) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Etlik City Hospital (Etlik Şehir Hastanesi)
Ankara, Ankara, 06010, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.